The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

DoP extends timeline for industry to file self-declaration under UCPMP for FY 2024-25: Gireesh Babu, New Delhi Monday, August 4, 2025, 08:00 Hrs [IST] The Department of Pharmaceut ...

Trump is using Section 232 and his Most Favoured Nation policy as twin levers in his push to lower drug prices.

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Evolving trade policies and tariffs strain bio/pharmaceutical manufacturers, affecting profits and operational strategies.

President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...